NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Canopus BioPharma Inc


Results 1 - 18


Refine Search
Display Mode: Context | Summary
Major Influenza Pandemic Threat is now Preventable and Treatable with Canopus’ Aerosol Statin Formulation
2009 MAY 25 ... Canopus BioPharma Inc. (OTCPK: CBIA) announced it has commissioned a team of experts led by Dr. Akihiro ...
Subject: Canopus BioPharma Inc.
Price: $3.00
*
Canopus Biopharma Announces Positive Results In Human Study of Novel Peptide Cancer Vaccine
2008 NOV 17 ... Canopus BioPharma, Inc. (OTC: CBIA; www.canopusbiopharma.com) announced that it has successfully ...
Subject: Cancer Vaccines
Price: $3.00
*
Canopus BioPharma Selected to Present its Drug Candidate for HIV/AIDS Treatment at the Global Summit on AIDS and the Church
2007 DEC 17 ... Pharmaceuticals, Therapies, Treatment, Viral Inhibition, Viral Therapy, Virology, Canopus BioPharma Inc. This article was prepared by AIDS Weekly editors from staff and other ...
Subject: Biopharmaceuticals
Price: $3.00
*
Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
2008 JUN 30 ... Mucositis, Oncology, Patents Actions, Pharmaceuticals, Therapies, Therapy, Treatment, Canopus BioPharma Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Canopus BioPharma, Inc.
Price: $3.00
*
Canopus BioPharma to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
2007 NOV 5 ... companies. Keywords: Biopharmaceuticals, Biotechnology, Pharmaceuticals, Canopus BioPharma Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Biopharmaceuticals
Price: $3.00
*
Canopus BioPharma to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference in Monte Carlo
2008 JUN 2 ... Biotechnology, Cancer, Drugs, Mental Health, Oncology, Pharmaceuticals, Therapies, Canopus BioPharma Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Canopus BioPharma, Inc.
Price: $3.00
*
Canopus BioPharma's StatC Drug Shows Superior Results for Treatment of Avian Flu and Other Influenzas
2007 AUG 13 ... Co. Ltd., Tamiflu, Treatment, Viral Inhibition, Viral Research, Viral Therapy, Virology, Canopus BioPharma Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Bird Flu
Price: $3.00
*
CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
2008 JUL 7 ... in the CB1400 pre-treated groups; all mice treated with placebo died. Canopus BioPharma Inc. has applied to undertake further clinical studies with leading oncologists in ...
Subject: Cancer
Price: $3.00
*
CB1400, Patented by Canopus BioPharma, Prevents Tumor Growth and Enhances the Anti-Tumor Effects of Cisplatin and Cetuximab (Erbitux).
2008 JUN 30 ... Pulmonology, Respiratory Infection, Therapies, Therapy, Treatment, Cetuximab, Canopus BioPharma Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Monoclonal Antibodies
Price: $3.00
*
Drake Holding Corp. Announces Completion of Stock Purchase Agreement with Canopus Corporation
2007 JUL 2 ... Drake Holding Corp. (DRKH.PK) consummated a Stock Purchase Agreement with Canopus Corporation, a Belize corporation controlled by Leo Prendergast and Patrick Prendergast, ... Directors and shareholders have voted to change the name of the corporation to Canopus BioPharma, Inc and to effectuate a 1 for 15 "reverse split" of the outstanding common shares of ...
Subject: Drake Holding Corp.
Price: $3.00
*
Drake Holding Corp. Announces Name Change to Canopus BioPharma, Inc. and New Stock Ticker Symbol of CBIA
2007 JUL 30 ... at www.canopusbiopharma.com. Keywords: Chemical Warfare, Pharmaceuticals, Canopus BioPharma Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Chemical Warfare
Price: $3.00
*
New Hepatitis C Antiviral CB5300 Identified by Canopus BioPharma Researchers to Enter Clinical Trial Assessment
2007 NOV 12 ... Pharmaceuticals, Therapies, Treatment, Viral Inhibition, Viral Therapy, Virology, Canopus BioPharma Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Biopharmaceuticals
Price: $3.00
*
Video: Canopus BioPharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
2008 AUG 25 ... Administration, Vaccines, Viral Inhibition, Viral Therapy, Virology, Virus, Zanamivir, Canopus BioPharma Inc. This article was prepared by Anti-Infectives Week editors from staff and ...
Subject: Bird Flu
Price: $3.00
*
Working with U.S. Department of Defense, Canopus BioPharma Announces Phase II Human Clinical Trial for Innovative Hepatitis C Drug, CB5300
2008 NOV 17 ... of Life, Therapies, Treatment, Viral Inhibition, Viral Load, Viral Therapy, Virology, Canopus BioPharma Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Canopus BioPharma, Inc.
Price: $3.00
*

Results 1 - 18




-----------------------
PR Login